16:02 Dec 20
Windlas Biotech Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Windlas Biotech Ltd.
75/100 High Financial Strength
Quality42/100 Mid Valuation
Valuation65/100 Technically Moderately Bullish
TechnicalSWOT
Strength
11
Weakness
2
Opportunity
1
Threat
1
2.16K
Market Cap (Cr)
35.21
PE Ratio
4.58
Price to Book Ratio
47.28
RSI
9.18 %
Net Profit Margin
SWOT
Download Our App On:
